|
Re: Resverlogix Announces Change in Fiscal Year-End to December 31
|
2
|
Resverlogix Corp.
|
Mar 14, 2021 06:05PM
|
|
Re: Resverlogix Announces Closing of $15 Million Offering
|
4
|
Resverlogix Corp.
|
Jun 07, 2019 09:22AM
|
|
Re: Resverlogix Announces Loan Reduction and Extension
|
3
|
Resverlogix Corp.
|
Aug 02, 2019 12:22PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
3
|
Resverlogix Corp.
|
Apr 01, 2020 03:01PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
3
|
Resverlogix Corp.
|
Apr 01, 2020 04:04PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
3
|
Resverlogix Corp.
|
Mar 31, 2020 02:46AM
|
|
Re: Resverlogix Announces Topline Results in BETonMACE Phase 3 Epigenetics Trial
|
1
|
Resverlogix Corp.
|
Sep 30, 2019 09:07AM
|
|
Re: Resverlogix Confirms Interim Filings on SEDAR
|
4
|
Resverlogix Corp.
|
Oct 05, 2020 08:51PM
|
|
Re: RESVERLOGIX CORP WTS 2021
|
3
|
Resverlogix Corp.
|
May 11, 2021 04:42PM
|
|
Re: RESVERLOGIX CORP.CODE OF BUSINESS CONDUCT AND ETHICS
|
1
|
Resverlogix Corp.
|
Sep 12, 2019 03:31PM
|
|
Re: RESVERLOGIX CORP.CODE OF BUSINESS CONDUCT AND ETHICS
|
2
|
Resverlogix Corp.
|
Sep 12, 2019 03:42PM
|
|
Re: Resverlogix In Active Discussions With The Kingdom of Morocco’s Ministry of Health For The Launch Of COVID-19 Clinical Studies With First-In-Class Dru
|
6
|
Resverlogix Corp.
|
Nov 01, 2021 09:45AM
|
|
Re: Resverlogix In Active Discussions With The Kingdom of Morocco’s Ministry of Health For The Launch Of COVID-19 Clinical Studies With First-In-Class Dru
|
8
|
Resverlogix Corp.
|
Nov 01, 2021 12:19PM
|
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
7
|
Resverlogix Corp.
|
Jun 22, 2020 12:14PM
|
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
6
|
Resverlogix Corp.
|
Jun 22, 2020 12:26PM
|
|
Re: Resverlogix spinout inks R&D deal with cancer institute
|
4
|
Resverlogix Corp.
|
Oct 05, 2020 03:26PM
|
|
Re: Revised target market, indications, market potential? ... and some numbers?
|
3
|
Resverlogix Corp.
|
Jun 13, 2020 10:43AM
|
|
Re: Revised target market, indications, market potential? ... and some numbers?
|
2
|
Resverlogix Corp.
|
Jun 13, 2020 03:53PM
|
|
Re: Right of first refusal
|
3
|
Resverlogix Corp.
|
Mar 02, 2019 03:16PM
|
|
Re: Right of first refusal
|
3
|
Resverlogix Corp.
|
Mar 02, 2019 06:29PM
|
